Successful Biopharmaceutical Operations
ebook ∣ Driving Change · Woodhead Publishing Series in Biomedicine
By C Driscoll
Sign up to save your library
With an OverDrive account, you can save your favorite libraries for at-a-glance information about availability. Find out more about OverDrive accounts.
Find this title in Libby, the library reading app by OverDrive.

Search for a digital library with this title
Title found at these libraries:
Library Name | Distance |
---|---|
Loading... |
Successful biopharmaceutical operations provides a practical guide to transforming biopharma companies into industry leaders through a focus on driving change. The industry has a blind spot concerning this kind of work, because successful change management comes from a focus on people, while our technically-minded ranks invariably prefer a technical focus. This cognitive bias causes us to pick up the tools we like the best and to swing them enthusiastically - whether they are working or not. This book provides new tools. Readers gain an understanding of how biopharma organizations developed into the cultures we see currently. They will recognize attributes and behaviours, and will come to understand their relationship to performance. Most importantly, readers learn what steps to take to transform biopharma operations. By giving real-world examples and context, the author provides a practical solution that readers can implement in their own organizations.
Staying the same is not an option for biopharmaceutical companies: organizations must keep pace with increasing regulatory scrutiny, global competition and constant cost pressure. The problem is that most organizations are not set up to demonstrate the agility necessary to get ahead and stay ahead.
Too many organizations in the industry continue to try to keep pace without fundamental change. Instead, they roll out Operational Excellence, Six Sigma, Lean, or the latest quality initiative. These activities provide comfort in that they occupy people and produce the appearance of productivity. Numbers are escalated that show dollars saved here or there, and the organization prides itself in the number of individuals it has trained in Lean or Six Sigma. Subsequent change, however, appears to be negligible.
Provides an insider's look at the transformation of real biopharmaceutical operations, thereby unveiling the lessons of technical industries, and revealing and tackling biopharma's blind spot Highlights the single management practice that is holding top performance hostage, and introduces the one change initiative that makes all other improvement possible. In doing so, the book debunks the myth that Lean and Six Sigma will deliver the industry to operational excellence Redefines 'High Performers' so organizations stop rewarding the wrong thing
Staying the same is not an option for biopharmaceutical companies: organizations must keep pace with increasing regulatory scrutiny, global competition and constant cost pressure. The problem is that most organizations are not set up to demonstrate the agility necessary to get ahead and stay ahead.
Too many organizations in the industry continue to try to keep pace without fundamental change. Instead, they roll out Operational Excellence, Six Sigma, Lean, or the latest quality initiative. These activities provide comfort in that they occupy people and produce the appearance of productivity. Numbers are escalated that show dollars saved here or there, and the organization prides itself in the number of individuals it has trained in Lean or Six Sigma. Subsequent change, however, appears to be negligible.